Key Highlights

  • Nano-X Imaging (NASDAQ:NNOX) rose 45.14% to USD 0.3391 on 20.6 million shares at a relative Volume of 20.05, with no catalyst identified in published coverage dated November 9 or 10, 2026.
  • MIND C.T.I. (NASDAQ:MNDO) climbed 43.80% to USD 1.2511 on 10.07 million shares at a relative volume of 268.22, while TTEC Holdings advanced 43.37% to USD 2.00 after results.
  • Humacyte (NASDAQ:HUMA) gained 28.08% to USD 0.5830 on a day of scheduled third-quarter results, and ZipRecruiter added 27.62% to USD 5.48 after lifting its outlook.
  • Market values spanned USD 25.49 million for MIND C.T.I. to USD 450.19 million for ZipRecruiter, and all five closed under USD 6.00 a share in the published screener snapshot.

Nano-X Imaging (NASDAQ:NNOX): Up 45.14% With No Identified Catalyst

Nano-X Imaging (NASDAQ:NNOX), an imaging company based in Israel, finished the regular session on Tuesday, November 10, 2026 at USD 0.3391, up 45.14% from a calculated prior close of USD 0.2336, or USD 0.1055 a share. Three lookups turned up no results release, trial update, financing or analyst action dated November 9 or 10, 2026, so no catalyst is identified in published coverage. As general context, sub-dollar stocks with deep losses often bounce hard on short covering or momentum. Volume was 20.6 million shares at a relative volume of 20.05, and a Market Value of USD 26.7 million implies about 78.7 million shares (calculated). The close sits 92.4% beneath the USD 4.44 reached on November 21, 2025, and USD 0.6609 under USD 1.00, so a Nasdaq minimum bid notice is a general risk and not a confirmed event. Trailing diluted EPS of USD -1.71 does not reconcile with that market value and is unconfirmed. A few trades can move the price, and nothing here suggests the move will continue.

MIND C.T.I. (NASDAQ:MNDO): Up 43.80% With No Identified Catalyst

MIND C.T.I. (NASDAQ:MNDO), a billing and messaging software company from Israel, finished the regular session at USD 1.2511, up 43.80% from a calculated prior close of USD 0.8700, or USD 0.3811 a share. Three lookups turned up no results release, dividend, Merger or filing dated November 9 or 10, 2026, so no catalyst is identified in published coverage. The background located is the August 6, 2026 report, which showed second-quarter Revenue of USD 4.6 million, Net Income of USD 0.8 million and cash and securities of USD 13.5 million at June 30, 2026. These are context and not confirmed drivers. Volume was 10.07 million shares at a relative volume of 268.22 against a calculated usual average near 37,544, and market value is USD 25.49 million with a P/E of 7.85. A Nasdaq bid price notice dated June 23, 2026 allows until December 21, 2026 to regain compliance, and the close sits 25.1% over USD 1.00 (calculated). A few trades can move the price, and the move may reverse.

TTEC Holdings (NASDAQ:TTEC): Up 43.37% on Third-Quarter Results and a Credit Extension

TTEC Holdings (NASDAQ:TTEC), a customer experience business, finished the regular session at USD 2.00, up 43.37% from a calculated prior close of USD 1.395, or USD 0.605 a share. The company issued third-quarter results on November 9, 2026. Revenue of USD 492.2 million declined 5.2%, non-GAAP EPS climbed to USD 0.22 from USD 0.12 and adjusted EBITDA reached USD 51.5 million versus USD 43.4 million. The release reaffirmed 2026 revenue guidance of USD 1,940 million to USD 1,990 million, and the company pushed its credit Facility term out to November 2028. The causal link is an inference from timing and not a confirmed statement. Volume was 3.3 million shares at a relative volume of 11.68, and market value is USD 98.59 million. Net Debt of USD 743.6 million is about 7.5 times that value (calculated), trailing diluted EPS is USD -4.30 and there is no P/E. Falling sales and covenant terms are risks, a few trades can move the price, and a 43.37% jump can reverse.

Humacyte (NASDAQ:HUMA): Up 28.08% on Scheduled Third-Quarter Results

Humacyte (NASDAQ:HUMA) finished the regular session at USD 0.5830, up 28.08% from a calculated prior close of USD 0.4552, or USD 0.1278 a share. The company had slated its third-quarter and nine-month 2026 results and an 8:00 a.m. ET webcast for November 10, 2026, yet published coverage did not show which single item drove the buying, and the figures in the release were not available for this review. Earlier items include an October 15 update that hospitals ordering Symvess grew 44%, from 34 to 49, and a September 9, 2026 FDA authorization stretching shelf life from 18 to 36 months. As general context, a stock under USD 1.00 often swings sharply on results days. Volume was 6.98 million shares at a relative volume of 1.62, and market value is USD 161.96 million, or about 277.8 million shares (calculated). Trailing diluted EPS of USD -0.49 points to a widening loss, and new Equity would dilute holders. A few trades can move the price, and nothing here suggests the move will continue.

ZipRecruiter (NYSE:ZIP): Up 27.62% on a Third-Quarter Beat and a Raised Outlook

ZipRecruiter (NYSE:ZIP) finished the regular session at USD 5.48, up 27.62% from a calculated prior close of USD 4.29, or USD 1.19 a share, following its November 9, 2026 release for the quarter ended September 30. The identified catalyst is the results beat and a higher outlook. Revenue was USD 124.4 million, up 8%, adjusted EBITDA was USD 20.8 million versus USD 9.2 million, and net income was USD 5.1 million versus a loss of USD 9.8 million. The 2026 revenue outlook now stands at USD 468 million to USD 472 million, with adjusted EBITDA of USD 61 million to USD 65 million. As general context, strong Operating Leverage can re-rate a stock quickly as margins widen. Market value is USD 450.19 million, the P/E is 15.87 on trailing diluted EPS of USD 0.35, and cash and securities of USD 174.7 million equal about 39% of market value (calculated). Volume was 883.73 thousand shares at a relative volume of 1.23. Hiring Demand is cyclical, revenue per paid employer slipped 2% to USD 1,683, and a jump this size can reverse.

Where Things Stand

The largest mover in this second group of market movers on November 10, 2026 was Nano-X Imaging, up 45.14%, and the common thread across the five names is big one-day gains on elevated volume, with four trading under USD 3.00. Three had results or an outlook behind the move, while Nano-X Imaging and MIND C.T.I. had no catalyst identified. The rankings rest on a published screener snapshot of the November 10, 2026 regular session. For investors in Canada watching US small caps, large gains in thinly traded names can reverse in the next session because a few trades can move the price.